02/28
Headlines

NASDAQ:ASPX

Losers At Healthcare: Synageva BioPharma (NASDAQ:GEVA), Auspex Pharmaceuticals (NASDAQ:ASPX), ImmunoGen (NASDAQ:IMGN), Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Mark Doerr02 mins

Synageva BioPharma Corp (NASDAQ:GEVA) last released its earnings data on Friday, May 2nd. The company reported ($1.16) earnings per share for the quarter, beating the analysts’ consensus estimate of ($1.19) by $0.03. Analysts expect that Synageva BioPharma Corp will post $-5.90 EPS for the current fiscal year. Synageva BioPharma Corp (NASDAQ:GEVA)stock performance was 5.87% in…

Read More
FB Nasdaq FB Facebook

Drug Manufacturers Most Volatile: ITI Inc (NASDAQ:ITCI), TherapeuticsMD Inc (NYSEMKT:TXMD), KaloBios Pharmaceuticals (NASDAQ:KBIO), Auspex Pharmaceuticals Inc (NASDAQ:ASPX)

Jason Knox02 mins

ITI Inc (NASDAQ:ITCI), a Company on the leading edge of transforming vaccines, announced the preliminary results of a Phase IB study of JRC-LAMP-vax™, a novel immunotherapy designed to treat individuals with allergy to Japanese red cedar (“JRC”). The Company is pleased to report that the Phase IB has met and maintained all primary safety and…

Read More